DETAILED NOTES ON MOUNJARO INJECTION 2.5 MG

one) and Drug Interactions (7)]. The potential risk of hypoglycemia may be lowered by a reduction within the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Notify clients working with these concomitant medications of the chance of hypoglycemia and educate them to the indicators and signs of hypoglycemia.